Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
Mu-Su Pan et al, 2020, Chinese Medicine CrossRef
Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells
Shuaishuai Huang et al, 2021, Acta Pharmaceutica CrossRef
Review targeted drug delivery systems for norcantharidin in cancer therapy
Bing-Tao Zhai et al, 2022, Journal of Nanobiotechnology CrossRef
Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF‐κB signaling pathway in vitro
Hsin‐Yu Chen et al, 2019, Environmental Toxicology CrossRef
Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma
Shujie Duan, 2018, Cancer Biomarkers CrossRef
Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro
Jia-Fang Liu et al, 2018, Molecules CrossRef
Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years
Jianbo Zhou et al, 2020, Biomedicine & Pharmacotherapy CrossRef
Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells
Gabriel Martínez-Razo et al, 2023, Pharmaceuticals CrossRef
MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway
Lei Yan et al, 2024, Cell Death Discovery CrossRef
Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells
Maximiliano V. M. Correa-Lara et al, 2023, Pharmaceuticals CrossRef
Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy
Ana Cavaco et al, 2017, International Journal of Molecular Sciences CrossRef